Form 4: Elanco Animal Health CEO Jeffrey Simmons Reports Stock Disposal
SEC Form 4 Filing
Elanco Animal Health CEO Jeffrey Simmons disposed of 75,721 shares of common stock to cover tax obligations, while still holding a significant number of shares directly and indirectly.
Summary
- On March 1, 2025, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving the disposal of 75,721 shares of common stock.
- The shares were disposed of at a price of $11.17 per share.
- This transaction was to cover tax obligations.
- Following the transaction, Simmons directly owns 1,537,127 shares of Elanco common stock.
- Simmons also indirectly owns 145,000 shares through a revocable trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a stock disposal for tax purposes, which is a routine transaction.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with company performance.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant given the relatively small number of shares disposed of compared to the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of stock disposal transaction. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.